Ro Appears in 84.3% of AI Answers. Here's Our Five-Step Plan to Improve Its AI Visibility.
This report supports CiteWorks Studio's examination of how AI search is recommending ED Treatment Pills. For more detail, you can also read ED Treatment Pills: AI Visibility Discovery Index.
On this report
Browse sections
- Answer Capsule
- Current AI visibility
- What changed since last month
- Next Step
- Step 1. Measure
- Step 2. Make the website consistent
- Step 3. Align the external narrative
- Step 4. Optimize priority company pages
- Step 5. Publish around buyer questions
- Our 90-day action plan
- Methodology
- Our first three priorities
- Learn More
Key Takeaways
- Ro appears in most AI answers for ED treatment pills, but first-place recommendations lag behind its overall recommendation rate.
- The main issue is placement, not reputation: mentions are largely positive and conflicting claims were not recorded in the sample.
- Priority work starts with verifying any uncertain company matches and checking cited third-party pages before requesting corrections.
- Ro’s own ED pages and recurring buyer questions offer the clearest opportunities for briefs that can improve how AI answers justify the brand.
Answer Capsule
In November 2026, Ro appeared in 237 of 281 AI answers included in the ED Treatment Pills benchmark (84.34%). It received 179 recommendations (63.70%), with 131 Top 3 placements and 20 first-place recommendations. A mention means the company appeared in an answer; a recommendation means the answer affirmatively endorsed it.
Our plan compares the company with its competitors, checks conflicting AI claims against reliable sources, and identifies website pages, third-party sources and buyer questions to address. The historical results show how the figures changed across available months. Different monthly samples limit those comparisons, and conflicting AI claims require verification before corrections are proposed.
Current AI visibility
Questions This Section Answers
- How do Ro mentions, recommendations and placements compare with its ED Treatment Pills peers?
Ro recorded 237 mentions (84.34%) and 179 recommendations (63.70%) across 281 answers included in the benchmark. Top 3 placements numbered 131; first-place recommendations numbered 20. Framing among its mentions was 180 positive, 54 neutral and 3 negative.
Rank | Company | Mentions | Mention rate | Recommendations | Recommendation rate | Top 3 | Top 3 rate | #1 | #1 rate |
|---|---|---|---|---|---|---|---|---|---|
1 | 252 | 89.68% | 189 | 67.26% | 144 | 51.25% | 75 | 26.69% | |
2 | Ro | 237 | 84.34% | 179 | 63.70% | 131 | 46.62% | 20 | 7.12% |
3 | 214 | 76.16% | 168 | 59.79% | 122 | 43.42% | 62 | 22.06% | |
4 | 111 | 39.50% | 92 | 32.74% | 40 | 14.23% | 6 | 2.14% | |
5 | 98 | 34.88% | 79 | 28.11% | 28 | 9.96% | 1 | 0.36% | |
6 | 68 | 24.20% | 33 | 11.74% | 16 | 5.69% | 2 | 0.71% | |
6 | 51 | 18.15% | 33 | 11.74% | 17 | 6.05% | 1 | 0.36% | |
8 | 20 | 7.12% | 20 | 7.12% | 12 | 4.27% | 5 | 1.78% | |
9 | 22 | 7.83% | 17 | 6.05% | 14 | 4.98% | 7 | 2.49% | |
10 | 17 | 6.05% | 15 | 5.34% | 5 | 1.78% | 1 | 0.36% |
Ro sits near the top of this category on reach, appearing in most answers and being recommended in a clear majority of them. That breadth is the asset to protect: the brand is already part of the default set of options AI answers present for ED treatment questions.
The weaker signal is first-place standing. Ro is named first far less often than its overall recommendation rate would suggest, and less often than the companies around it. Being on the list and being the answer are different outcomes, and the gap is where the commercial value sits.
Framing is largely positive, with few negative mentions, so the constraint is not reputation. We would treat the placement gap as the priority question and build the first scorecard around it, separating how often Ro appears from how often it leads.
What changed since last month
Questions This Section Answers
- How did Ro counts and coverage differ across the available monthly snapshots?
Metric | Oct 2026 | Nov 2026 |
|---|---|---|
Mentions | 244 / 296 (82.43%) | 237 / 281 (84.34%) |
Recommendations | 163 / 296 (55.07%) | 179 / 281 (63.70%) |
Top 3 recommendations | 125 / 296 (42.23%) | 131 / 281 (46.62%) |
#1 recommendations | 29 / 296 (9.80%) | 20 / 281 (7.12%) |
Only months with verified results are shown. Monthly sample coverage is listed in Methodology.
From October 2026 to November 2026, Ro's mention count fell from 244 to 237, while its recommendation count rose from 163 to 179. The recommendation rate was 55.07% and 63.70% respectively.
Between the two recorded months, Ro's mention count eased while its recommendation count rose. The recommendation rate moved up alongside that. These are separate observations from two selected samples, and the report does not establish what produced either movement.
The first-place count fell over the same period, which is the movement worth watching most closely given the placement gap described above. Because the answer samples differ between months, the two months should be read as snapshots rather than a trend line.
We would set the next scorecard to track reach, recommendation and first-place standing as distinct measures, so future movement can be read without conflating them.
AI recommendation trend
Observed recommendation rate (%), Oct 2026 to Nov 2026
- Ro+8.63 ppOct 202655.07%Nov 202663.70%
Separate selected monthly samples. Missing points are unavailable, not zero. Provider/prompt equivalence is unverified; rate movement does not demonstrate causation.
/ Take the next step
Want to Understand Your AI Citation Footprint?
We start every engagement with a full audit of how AI systems reference your brand today.
Measurable, Repeatable Programme
Build a durable foundation of credible citations that compounds over time and continues to influence AI answers as new queries emerge
Citation Architecture Review
Identify which high-authority community sources are and aren't working in your favour across AI platforms.
AI Visibility Audit
Understand exactly how LLMs are referencing your brand today and which sources are shaping those answers.
Step 1. Measure
Questions This Section Answers
- What should the agency measure and verify first for Ro?
AI answers contained 0 conflicting claims about Ro: 0 critical, 0 high, 0 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.
Another 1 possible conflicts were excluded because the company match was uncertain. They need an identity check before substantive review.
No conflicting claims about Ro were recorded in the captured answers, and one possible conflict was set aside because the company match could not be confirmed. That is a clean starting position, but a clean count is not the same as verified accuracy.
A visibility comparison would show where Ro appears, how it is framed and where it leads, giving the client a single view of reach and placement. A scoped list of claims to fact-check would then direct effort only where an answer makes a specific assertion about the company.
The uncertain match should be resolved by identity check before any substantive review, and it stays outside the correction queue until then.
Step 2. Make the website consistent
Questions This Section Answers
- Which recorded claim differences about Ro should be verified before proposed page edits?
No results are available for this part of the analysis.
Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.
No results are available for this part of the analysis, so there are no disputed topics to brief against yet. The work here is therefore preparatory: confirm which entity each answer refers to, which date applies and what source sits behind any claim before treating it as a conflict.
Different dates can make two statements look contradictory when they are not. We would resolve entity, date and source first, then decide whether a page brief is warranted at all.
Where a brief is justified, it would be built on approved facts and current primary-source verification rather than on the wording of an AI answer.
Step 3. Align the external narrative
Questions This Section Answers
- Which cited third-party pages are relevant to fact review for Ro?
Cited page selected for review | Citation appearances in all captured answers | Answers mentioning the company | Conflicting claims linked to this page |
|---|---|---|---|
https://goodrx.com/sildenafil/viagra-now-available-directly-online | 64 | 45 | 0 |
https://walgreens.com/topic/virtual-healthcare/sexual-health/sildenafil.jsp | 54 | 40 | 0 |
https://goodrx.com/care/services/erectile-dysfunction/sildenafil-online | 50 | 38 | 0 |
https://goodrx.com/care/services/erectile-dysfunction | 44 | 36 | 0 |
https://lemonaidhealth.com/drug/viagra | 40 | 34 | 0 |
https://hims.com/erectile-dysfunction/sildenafil | 56 | 33 | 0 |
These pages were selected because they relate to the company in the captured answers. Their current contents still need checking before any correction request. A page linked to a conflicting claim is not necessarily its cause, and the same answer may contribute to more than one row.
The cited pages selected for review are mostly third-party health and pharmacy sites, alongside one competitor page. Each was chosen because it relates to Ro in captured answers, and none carries a linked conflicting claim. Citation is not evidence of influence, so these pages are candidates for review, not targets for correction.
We would check the current contents of the highest-appearance pages first, confirm what they actually say about Ro, and only then consider whether an evidence-backed request to a publisher is justified.
Requests would be framed around verified facts, with no assumption that a publisher has erred or that a page controls how AI answers describe the company.
Step 4. Optimize priority company pages
Questions This Section Answers
- Which observed Ro website pages should receive review briefs?
Company website page | Citation appearances in all captured answers | Benchmark answers citing the page | Recommending answers citing the page |
|---|---|---|---|
https://ro.co/erectile-dysfunction/viagra-prescription/ | 50 | 27 | 25 |
https://ro.co/erectile-dysfunction/viagra/ | 40 | 31 | 28 |
https://ro.co/erectile-dysfunction/cialis/ | 26 | 16 | 15 |
https://ro.co/erectile-dysfunction/ | 23 | 20 | 18 |
https://ro.co/erectile-dysfunction/cialis-over-the-counter/ | 18 | 11 | 10 |
https://ro.co/erectile-dysfunction/ro-vs-hims/ | 15 | 0 | 0 |
https://ro.co/hair-loss/finasteride-over-the-counter/ | 11 | 0 | 0 |
https://ro.co/erectile-dysfunction/sparks/ | 10 | 1 | 1 |
The company's website was cited 358 times across 84 distinct page addresses; the table shows 8 pages selected for review. Zeros in the answer columns mean no matching answers were recorded. A cited page is not automatically a page that accompanied a recommendation.
Ro's own site is cited widely across many distinct addresses, and a small set of ED pages accounts for much of that attention. Several of those pages appear in answers that recommend the company, which makes them the natural starting point for page briefs.
Some listed pages, including the comparison and over-the-counter pages, recorded no matching recommending answers. That absence is an observation about this sample, not proof that the pages underperform or that content is missing.
We would brief the priority pages using approved facts and the buyer questions recorded in the research, and check existing coverage before proposing anything new.
Step 5. Publish around buyer questions
Questions This Section Answers
- Which observed buyer questions support content briefs for Ro?
Question observed in the research | Benchmark answers to this question | Company mentions | Company recommendations |
|---|---|---|---|
What are the best online ED pills? | 3 | 3 | 3 |
What is the best online treatment for ED? | 3 | 3 | 3 |
What's the best ED medication online? | 3 | 3 | 3 |
What are the top telemedicine companies? | 4 | 3 | 2 |
What is the best online ED medication? | 3 | 3 | 2 |
What's the best ED treatment online? | 3 | 3 | 2 |
What is the best online pharmacy for weight loss? | 2 | 2 | 2 |
What is the best online prescription? | 3 | 2 | 2 |
These are recorded answer observations, not search volume, verified demand, or proof of missing website content.
The recorded questions cluster around best-online-treatment and best-online-pharmacy phrasing, and Ro is mentioned in nearly all of them. Recommendations are slightly less consistent than mentions, which suggests the opportunity lies in how answers justify a pick rather than in whether Ro is named.
These are answer observations, not search volume or verified demand. We would check existing coverage against each question before drafting anything, then prepare buyer-question content briefs that answer the comparison directly with approved facts.
Where a page already addresses a question, the brief would focus on sharpening it rather than adding a duplicate.
Our 90-day action plan
Questions This Section Answers
- How should the agency sequence the proposed Ro work and judge completion?
Period | Deliverable | Completion criterion |
|---|---|---|
Days 1–30 | Baseline scorecard, scoped fact-review register and page/source shortlist | Each record has an owner, evidence requirement and review status |
Days 31–60 | Approved page briefs and justified publisher requests | Separate confirmed edits, no-change decisions, requests and responses |
Days 61–90 | Buyer-content briefs and a fresh scorecard | Record work completed separately from measured answer outcomes and comparability limits |
The first month establishes the baseline: a scorecard, a scoped fact-review register and a shortlist of pages and sources, each with an owner, an evidence requirement and a review status. Nothing moves to correction until identity and source are confirmed.
The second month produces approved page briefs and any publisher requests that survive verification, with confirmed edits, no-change decisions, requests and responses recorded separately. The third month adds buyer-content briefs and a fresh scorecard.
Delivered work will be reported apart from measured answer outcomes. Completing a brief or a request does not establish that visibility changed, and the monthly comparability limits will be stated alongside any future results.
Methodology
Questions This Section Answers
- How are Ro answer metrics and citation populations defined?
This report covers 2026-11. The exact dates when the original AI answers were collected have not been verified. The visibility rates use 281 answers that met the benchmark's inclusion rules. A company is recommended only when the answer both endorses it and uses positive wording. Top 3 and first-place counts are part of those recommendations, not extra recommendations.
An answer can mention or recommend several companies, so company counts cannot be added to find the number of distinct answers. The net sentiment score is positive minus negative mentions, divided by all company mentions; it describes answer wording, not customer satisfaction.
The wider citation analysis covers 800 captured answers and 5650 appearances of cited URLs. Citation appearances across all captured answers differ from the number of benchmark answers citing a page and the number that also recommend a company. The current contents of cited pages and disputed company claims still need independent verification.
Monthly sample coverage:
Reporting month | Answers included | AI services covered | Services |
|---|---|---|---|
Oct 2026 | 296 | 6 | ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, Perplexity |
Nov 2026 | 281 | 6 | ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, Perplexity |
July 2026 measured a different set of companies, so it is excluded from this comparison. August 2026 measured a different set of companies, so it is excluded from this comparison. September 2026 measured a different set of companies, so it is excluded from this comparison.
The answer samples differ between months. These comparisons show how the recorded results changed; they do not establish why they changed.
The report covers a single month, and the exact dates the original answers were collected have not been verified. Visibility rates rest on the answers that met the benchmark's inclusion rules, and a recommendation requires both endorsement and positive wording.
An answer can mention or recommend several companies, so company counts cannot be added to find distinct answers. Sentiment describes answer wording, not customer satisfaction. The wider citation analysis covers a larger set of captured answers, and citation appearances differ from benchmark answers citing a page.
The monthly samples differ, so comparisons show how recorded results changed, not why. Cited page contents and disputed claims still need independent verification.
Our first three priorities
First, resolve the one uncertain company match so the fact-review register is clean, and confirm that no recorded conflict requires action. This is quick work but it gates everything downstream.
Second, brief the Ro ED pages that already appear in recommending answers, using approved facts and the recorded buyer questions, and check existing coverage before proposing new content. The placement gap makes these pages the most direct lever on first-place standing.
Third, review the highest-appearance external pages for what they currently say about Ro, and prepare evidence-backed requests only where verification supports one. Throughout, keep reach, recommendation and first-place standing as separate measures so progress is read honestly.
/ Learn More
Understanding AI search visibility.
AI search experiences create answers by pulling information from many places online and summarizing it into a single response.
What Is AI Citation Intelligence?
What Is Citation Architecture?
What Is Generative Engine Optimization?
What Is AI Share of Voice?
Archived editions
Browse earlier published research snapshots for this article. The latest edition remains at the current URL.


